Trials / Terminated
TerminatedNCT04342897
A Study of LY3127804 in Participants With COVID-19
A Randomized, Double-blind, Placebo-controlled, Clinical Trial of LY3127804 in Patients Who Are Hospitalized With Pneumonia and Presumed or Confirmed COVID-19
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 95 (actual)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A randomized, double-blind, placebo-controlled, clinical trial of LY3127804 in participants who are hospitalized with pneumonia and presumed or confirmed COVID-19.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LY3127804 | Administered IV |
| DRUG | Placebo | Administered IV |
Timeline
- Start date
- 2020-04-20
- Primary completion
- 2020-10-12
- Completion
- 2020-10-12
- First posted
- 2020-04-13
- Last updated
- 2021-08-12
- Results posted
- 2021-08-12
Locations
13 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04342897. Inclusion in this directory is not an endorsement.